Clinical Trial Update: Comparison for the Effect of Neuromuscular Blocking Agents Versus Sedation Alone on Severe ARDS Patients Due to COVID-19 [NA]

View source ↗

Summary

The document is a clinical trial update noting completion of a study comparing neuromuscular blocking agents versus sedation alone in patients with severe acute…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Neuromuscular blocking agents

Snippet

Sponsor: Assiut University | Conditions: COVID-19 Acute Respiratory Distress Syndrome, Sedation Complication | NA | Status: COMPLETED